Samsara Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 18

Samsara Therapeutics General Information

Description

Developer of therapeutics drug designed for the treatment of neurodegenerative and age-related diseases. The company creates a pipeline for the identification, chemical optimization, and in vivo validation of compounds that extend a healthy lifespan and treat rare genetic diseases by autophagy, enabling physicians to validate compounds across species that are protective in mammalian models of diseases.

Contact Information

Website
www.samsaratherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Science Oxford Centre
  • Quarry Road, Headington
  • Oxford OX3 8SB
  • England, United Kingdom
+44 01865
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Science Oxford Centre
  • Quarry Road, Headington
  • Oxford OX3 8SB
  • England, United Kingdom
+44 01865

Samsara Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Samsara Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 27-Nov-2024 Completed Pre-Clinical Trials
3. Early Stage VC (Series A) 14-Dec-2022 Completed Pre-Clinical Trials
2. Early Stage VC 15-Jul-2021 $10.3M $13.5M Completed Pre-Clinical Trials
1. Seed Round 20-Dec-2019 $3.2M $3.2M Completed Pre-Clinical Trials
To view Samsara Therapeutics’s complete valuation and funding history, request access »

Samsara Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Pre Series A
Seed
To view Samsara Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Samsara Therapeutics Patents

  • 20

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 12

    Pending

  • Expiring in next 12 mo

Samsara Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025264820-A1 Azetidine derivatives for inducing autophagy and uses thereof Pending 19-Jun-2024
EP-4653432-A1 Autophagy inducing compounds and uses thereof in the prevention or therapy of diseases Pending 24-May-2024
WO-2025242565-A1 Autophagy inducing compounds and uses thereof in the prevention or therapy of diseases Pending 24-May-2024
EP-4653430-A1 Autophagy inducing compounds and uses thereof, in particular for the prevention or treatment of diseases of the cns Inactive 24-May-2024
WO-2025242566-A1 Autophagy inducing compounds and uses thereof, in particular for the prevention or treatment of diseases of the cns Pending 24-May-2024 C07D413/14
To view Samsara Therapeutics’s complete patent history, request access »

Samsara Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Samsara Therapeutics Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Felix Jahn Beteiligungen Venture Capital Minority
CMT Research Foundation Not-For-Profit Venture Capital Minority
CoastCap Family Office Minority
Healthspan Capital Venture Capital Minority
3e Capital Group Family Office Minority
You’re viewing 5 of 18 investors. Get the full list »

Ready to get started?

Request a free trial

Samsara Therapeutics FAQs

  • When was Samsara Therapeutics founded?

    Samsara Therapeutics was founded in 2018.

  • Where is Samsara Therapeutics headquartered?

    Samsara Therapeutics is headquartered in Oxford, United Kingdom.

  • What is the size of Samsara Therapeutics?

    Samsara Therapeutics has 15 total employees.

  • What industry is Samsara Therapeutics in?

    Samsara Therapeutics’s primary industry is Drug Discovery.

  • Is Samsara Therapeutics a private or public company?

    Samsara Therapeutics is a Private company.

  • What is Samsara Therapeutics’s current revenue?

    The current revenue for Samsara Therapeutics is .

  • How much funding has Samsara Therapeutics raised over time?

    Samsara Therapeutics has raised $13.7M.

  • Who are Samsara Therapeutics’s investors?

    Felix Jahn Beteiligungen, CMT Research Foundation, CoastCap, Healthspan Capital, and 3e Capital Group are 5 of 18 investors who have invested in Samsara Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process